93 related articles for article (PubMed ID: 32366479)
1. ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a "Toggle Switch" of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells.
Almairac F; Turchi L; Sakakini N; Debruyne DN; Elkeurti S; Gjernes E; Polo B; Bianchini L; Fontaine D; Paquis P; Chneiweiss H; Junier MP; Verrando P; Burel-Vandenbos F; Virolle T
Cancer Res; 2020 Aug; 80(16):3236-3250. PubMed ID: 32366479
[TBL] [Abstract][Full Text] [Related]
2. Anarchy or Respect the Hierarchy? The Complexity of Glioblastoma.
Koncar RF; Agnihotri S
Cancer Res; 2020 Aug; 80(16):3195-3196. PubMed ID: 32817015
[TBL] [Abstract][Full Text] [Related]
3. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
4. Nanog promotes stem-like traits of glioblastoma cells.
Yuan Y; Zhang M; Yan G; Ma Q; Yan Z; Wang L; Yang K; Guo D
Front Biosci (Landmark Ed); 2021 Jan; 26(3):552-565. PubMed ID: 33049683
[TBL] [Abstract][Full Text] [Related]
5. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells.
Moon JH; Kwon S; Jun EK; Kim A; Whang KY; Kim H; Oh S; Yoon BS; You S
Biochem Biophys Res Commun; 2011 Aug; 412(1):175-81. PubMed ID: 21810410
[TBL] [Abstract][Full Text] [Related]
6. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B
Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661
[TBL] [Abstract][Full Text] [Related]
10. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
11. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness.
Lee SH; Chen TY; Dhar SS; Gu B; Chen K; Kim YZ; Li W; Lee MG
Nucleic Acids Res; 2016 Dec; 44(22):10603-10618. PubMed ID: 27625395
[TBL] [Abstract][Full Text] [Related]
12. NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades.
Freitag D; McLean AL; Simon M; Koch A; Grube S; Walter J; Kalff R; Ewald C
Mol Carcinog; 2017 Aug; 56(8):1953-1964. PubMed ID: 28345785
[TBL] [Abstract][Full Text] [Related]
13. Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.
Kuciak M; Mas C; Borges I; Sánchez-Gómez P; Ruiz I Altaba A
Sci Rep; 2019 Mar; 9(1):3891. PubMed ID: 30846719
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
[TBL] [Abstract][Full Text] [Related]
15. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
16. Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
Ding Y; Yu AQ; Wang XL; Guo XR; Yuan YH; Li DS
Oncol Rep; 2016 May; 35(5):2643-50. PubMed ID: 26936116
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
Olmez I; Shen W; McDonald H; Ozpolat B
J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
[TBL] [Abstract][Full Text] [Related]
19. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas.
Flüh C; Hattermann K; Mehdorn HM; Synowitz M; Held-Feindt J
Int J Oncol; 2016 Apr; 48(4):1408-16. PubMed ID: 26821357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
